Drug-Induced Deficits in Color Perception: Implications for Vision Rehabilitation Professionals

Azzouni F. , & Abu Samra K. (2011). Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature. Journal of Sexual Medicine, 8(10), 2894–2903. doi: 10.1111/j.1743-6109.2011. 02382.x

Carlson L. , & Buck M. (2002). Pharmaceutical agents (Report). Aleda Lutz Veterans Affairs Medical Center, Saginaw, Michigan.

Cooper B. Gowland C. , & McIntosh J. (1986). The use of color in the environment of the elderly to enhance function. Clinics of Geriatric Medicine, 2(1), 151–162.

Cooper B. A. Ward M. Gowland C. A. , & McIntosh J. M. (1991). The use of the Lanthony New Color Test in determining the effects of aging on color vision. Journal of Gerontology, 46(6), 320–324.

Delpero W. T. O'Neill H. Casson E. , & Hovis J. (2005). Aviation-relevent epidemiology of color vision deficiency. Aviation, Space, and Environmental Medicine, 76(2), 127–133.

Du X. Ninomiya T. de Galan B. Abadir E. Chalmers J. Pillai A. Woodward M. , … Poulter N. (2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: Results of the ADVANCE study. European Heart Journal, 30(9), 1128–1135. doi: http://dx.doi.org/10.1093/eurheartj/ehp055

Glynn R. J. Monane M. Gurwitz J. H. Choodnovskiy I. , & Avorn J. (1999). Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. Journal of Clinical Epidemiology, 52(8), 781–790. doi: http://dx.doi.org/10.1016/S0895-4356(99)00055-4

Grover S. A. Lowensteyn I. Kaouache M. Marchand S. Coupal L. De Carolis E. Zoccoli J. , & Defoy I. (2006). The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Archives of Internal Medicine, 166(2), 213–219. doi: 10.1001/archinte.166.2.213

Hasrod N. , & Rubin A. (2015). Color vision: A review of the Cambridge Color Test and other color testing methods. African Vision and Eye Health, 74(1), 1–7. doi: 10.4102/aveh.v74i1.23

Jafarzadehpur E. Hashemi H. Emamian M. H. Khabazkhoob M. Mehravaran S. Shariati M. , & Fotouhi A. (2014). Color vision deficiency in a middle-aged population: The Shahroud Eye Study. International Ophthalmology, 34(5), 1067–1074. doi: 10.1007/s10792-014-9911-2

Laties A. M. , & Zrenner E. (2002). Viagra (sildenafil citrate) and ophthalmology. Progress in Retinal and Eye Research, 21(5), 485–506. doi: 10.1016/S1350-9462(02)00013-7

Lawrenson J. Kelly C. Lawrenson A. , & Birch J. (2002). Acquired colour vision deficiency in patients receiving digoxin maintenance therapy. British Journal of Ophthalmology, 86(11), 1259–1261. doi: 10.1136/bjo.86.11.1259

Li J. Tripathi R. C. , & Tripathi B. J. (2008). Drug-induced ocular disorders. Drug Safety, 31(2), 127–141. doi: 10.2165/00002018-200831020-00003

Nicolosi A. Moreira E. D. Shirai M. Tambi M. I. B. M. , & Glasser D. B. (2003). Epidemiology of erectile dysfunction in four countries: Cross-national study of the prevalence and correlates of erectile dysfunction. Urology, 61(1), 201–206. doi: 10.1016/S0090-4295(02)02102-7

Ramage-Morin P. (2009). Medication use among senior Canadians. Health Reports, 20(1), 37–44.

Rigby H. S. Warren B. F. Diamond J. Carter C. , & Bradfield J. W. (1991). Color perception in pathologists: The Farnsworth-Munsell 100-Hue Test. Journal of Clinical Pathology, 44(9), 745–748.

Rodriguez-Carmona M. L. Harlow A. J. Walker G. , & Barbur J. L. (2005). The variability of normal trichromatic vision and the establishment of the “normal” range. Proceedings of 10th Congress of the International Color Association, Granada, 979–982.

Santaella R. M. , & Fraunfelder F. W. (2007). Ocular adverse effects associated with systemic medications. Drugs, 67(1), 75–93. doi: 0012-6667/07/0001-0075

Simunovic M. P. (2010). Colour vision deficiency. Eye, 24(5), 747–755. doi: 10.1038/eye.2009.251

Simunovic M. P. (2016). Acquired color vision deficiency. Survey of Ophthalmology, 61(2), 132–155. doi:10.1016/j.survophthal.2015.11.004

Statistics Canada. (2015). Arthritis. Retrieved from http://www.statcan.gc.ca/pub/82-229-x/2009001/status/art-eng.htm#re

Stockman A. Sharpe L. T. Tufail A. Kell P. D. Ripamonti C. , & Jefferey G. The effect of sildenafil citrate (Viagra). on visual sensitivity. (2007). Journal of Vision, 7(8), 1–5.

Wong B. (2011). Points of view: Color blindness. Nature Methods, 8(6), 441–441. doi: 10.1038/nmeth.1618

Yancik R. Ries L. G. , & Yates J. W. (1989). Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer, 63(5), 976–981. doi: 10.1002/1097-0142